Total Payments
$6,701
2024 Payments
$1,161
Companies
35
Transactions
354
Medicare Patients
1,114
Medicare Billing
$64,677
Payment Breakdown by Category
Food & Beverage$6,405 (95.6%)
Education$296.33 (4.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,405 | 339 | 95.6% |
| Education | $296.33 | 15 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,069 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $911.40 | 33 | $0 (2024) |
| Lilly USA, LLC | $690.98 | 46 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $571.22 | 17 | $0 (2019) |
| Astellas Pharma US Inc | $367.29 | 16 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $323.13 | 11 | $0 (2019) |
| Allergan Inc. | $286.42 | 25 | $0 (2019) |
| Amarin Pharma Inc. | $283.75 | 6 | $0 (2017) |
| PFIZER INC. | $273.64 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $261.17 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,161 | 51 | Novo Nordisk Inc ($258.16) |
| 2022 | $100.94 | 1 | AstraZeneca Pharmaceuticals LP ($100.94) |
| 2021 | $27.05 | 2 | Amgen Inc. ($27.05) |
| 2020 | $115.10 | 1 | Esperion Therapeutics, Inc. ($115.10) |
| 2019 | $687.71 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($152.86) |
| 2018 | $1,894 | 107 | Janssen Pharmaceuticals, Inc ($421.24) |
| 2017 | $2,716 | 149 | Novo Nordisk Inc ($548.73) |
All Payment Transactions
354 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Cardio-renal | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Endocrinology | ||||||
| 09/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: PAIN | ||||||
| 09/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: Cardio-renal | ||||||
| 08/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Cardio-renal | ||||||
| 08/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.39 | General |
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Diabetes | ||||||
| 07/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $6.65 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 164 | 192 | $36,795 | $15,745 |
| 2022 | 7 | 154 | 212 | $17,071 | $4,788 |
| 2021 | 13 | 420 | 669 | $61,060 | $25,758 |
| 2020 | 13 | 376 | 570 | $45,733 | $18,385 |
Total Patients
1,114
Total Services
1,643
Medicare Billing
$64,677
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 135 | $29,700 | $12,778 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 42 | $6,720 | $2,806 | 41.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 15 | $375.00 | $161.55 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 49 | $9,310 | $2,809 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 17 | $2,278 | $780.70 | 34.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 24 | 28 | $1,875 | $373.09 | 19.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 26 | 35 | $1,850 | $367.63 | 19.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 21 | 26 | $687.18 | $201.22 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 31 | 44 | $440.00 | $131.25 | 29.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 13 | $631.15 | $125.24 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 154 | $28,897 | $12,246 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 34 | 34 | $5,814 | $4,424 | 76.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 65 | $8,575 | $3,700 | 43.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 23 | 23 | $1,702 | $1,501 | 88.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 42 | 67 | $4,486 | $897.13 | 20.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 46 | 75 | $3,964 | $792.00 | 20.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 43 | 56 | $1,480 | $435.12 | 29.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 16 | 41 | $1,517 | $423.32 | 27.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 25 | $925.00 | $411.75 | 44.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 15 | 18 | $1,511 | $302.40 | 20.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 17 | 25 | $1,214 | $242.75 | 20.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 43 | 73 | $730.00 | $219.00 | 30.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 13 | 13 | $245.04 | $163.80 | 66.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 126 | $19,782 | $8,485 | 42.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 83 | $8,881 | $3,805 | 42.8% |
About Dr. Blanca Gray, MD
Dr. Blanca Gray, MD is a Internal Medicine healthcare provider based in Corpus Christi, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811905789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Blanca Gray, MD has received a total of $6,701 in payments from pharmaceutical and medical device companies, with $1,161 received in 2024. These payments were reported across 354 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,405).
As a Medicare-enrolled provider, Gray has provided services to 1,114 Medicare beneficiaries, totaling 1,643 services with total Medicare billing of $64,677. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Corpus Christi, TX
- Active Since 08/04/2006
- Last Updated 07/25/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811905789
Products in Payments
- FARXIGA (Drug) $692.89
- Victoza (Drug) $441.15
- XARELTO (Drug) $393.32
- TRULICITY (Drug) $328.23
- Vascepa (Drug) $283.75
- Ozempic (Drug) $247.09
- MOUNJARO (Drug) $243.41
- XIFAXAN (Drug) $178.06
- INVOKANA (Drug) $177.90
- Kerendia (Drug) $172.03
- BEVESPI AEROSPHERE (Drug) $147.86
- SOLIQUA (Drug) $145.21
- JARDIANCE (Drug) $139.82
- BYSTOLIC (Drug) $129.54
- TOUJEO (Drug) $116.93
- NEXLIZET (Drug) $115.10
- Cologuard Collection Kit (Device) $110.67
- Amitiza (Drug) $92.98
- LONHALA MAGNAIR (Drug) $92.05
- Korlym (Drug) $90.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Corpus Christi
Kenechukwu Enekebe, M.d, M.D
Internal Medicine — Payments: $311,322
Internal Medicine $311,322
Dr. Tarun Madappa, M.d, M.D
Internal Medicine — Payments: $114,904
Internal Medicine $114,904
Dr. John Pappas, M.d, M.D
Internal Medicine — Payments: $39,308
Internal Medicine $39,308
Dr. Travis Taylor, Md, MD
Internal Medicine — Payments: $38,111
Internal Medicine $38,111
Dr. Mossaab Shuraih, M.d, M.D
Internal Medicine — Payments: $35,944
Internal Medicine $35,944
Michael Lovoi, Md, MD
Internal Medicine — Payments: $21,210
Internal Medicine $21,210